Growth and endocrine function after chemotherapy and radiotherapy in childhood.
Spoudeas
Helen A
HA
London Centre for Paediatric Endocrinology, UCLH and GOSH Hospitals, Neuro-Endocrine/Oncology Division, 3rd Floor Dorville House, Middlesex Hospital, Mortimer Sreet, London, UK. h.spoudeas@ucl.ac.uk
D000970:Antineoplastic Agents / Q000009:adverse effects; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D002648:Child; D016371:Cranial Irradiation / Q000009:adverse effects; D004700:Endocrine System Diseases / Q000139:chemically induced*; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000209:etiology*; D013006:Growth Hormone / Q000172:deficiency; D006801:Humans; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D017741:Survivors
D000970:Antineoplastic Agents; D013006:Growth Hormone